市場調查報告書
商品編碼
1443434
PET影像市場:2024年2024 PET Imaging Market Summary Report |
PET 影像在過去二十年中不斷發展,已成為癌症患者診斷和管理的支柱。儘管腫瘤檢測仍佔 PET 檢查的大部分,但新的放射性藥物有望提高心臟病學和神經病學 PET 檢查的有效性。
本報告提供全球PET影像市場相關調查,彙整市場概要,以及PET影像設備的安裝據點與購買計劃,與PET放射性醫藥品的使用預算,PET網站的營運與特徵等資料。
PET imaging has grown over the past two decades to become a mainstay in the diagnosis and management of cancer patients. While oncology scans continue to comprise the majority of PET scans, new radiopharmaceuticals offer the promise of increasing the efficacy of PET imaging for cardiology and neurology.
IMV's “2024 PET Imaging Market Summary Report” monitors trends in PET scan utilization, the adoption of fixed PET scanners (e.g., PET-only, PET/CT, and PET/MR), the use of mobile PET services, purchase plans, and radiopharmaceutical use. Survey results are projected to the universe of facilities using PET, and the report addresses the PET unit market for 2024-2026.
This “2024 PET Imaging Market Summary Report” summarizes the results from IMV Medical Information Division's 2023 PET Census of hospital and non-hospital facilities performing PET imaging in the United States. The universe of PET sites for this study is defined as any location where PET scans are performed using a fixed PET-only, fixed PET/CT, fixed PET/MR, or a PET-only or PET/CT scanner provided by a mobile van service. The responses from the 509 PET imaging professionals have been projected to IMV's identified universe of hospitals and imaging/PET centers that perform PET imaging using fixed or mobile PET equipment.